Skin Cancer

Survey findings inform messaging on UV exposure
July 31, 2020

Findings from a survey of college students examining beliefs about UV exposure and sunscreen use and their associations with skin cancer risk and UV protective behaviors provide some insights for patient counseling.

FDA approves combination treatment for advanced melanoma
July 30, 2020

The U.S. Food and Drug Administration has approved atezolizumab plus cobimetinib and vemurafenib for treatment of BRAF V600 mutation-positive advanced melanoma. Studies show the combination treatment prolonged patients’ lives by 15 months without disease worsening.

Studies examine ingredient safety over lifetime use
July 30, 2020

Findings of initial studies and call for further testing should not be misconstrued to mean ingredients are unsafe.